Disc Medicine Prices Upsized $450 Million Stock Offering at $75 a Share

By Public Technologies
  • Disc Medicine priced an upsized public offering of common stock expected to raise $450 million in gross proceeds before expenses.
  • The offering comprises 6,000,000 shares at $75 per share.
  • Underwriters have a 30-day option to purchase up to 900,000 additional shares at the offering price, less underwriting discounts and commissions.
  • Closing is expected on October 22, 2026, subject to customary conditions.
  • Net proceeds will support clinical development, potential bitopertin commercialization for EPP and XLP, other pre-commercialization activities and general corporate purposes.


Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Disc Medicine Inc. i published the original content used to generate this news brief via GlobeNewswire (Ref. ID: 202610202052PRIMZONEFULLFEED9850027) on October 21, 2026, and is solely responsible for the information contained therein.

Capital.com is an execution-only brokerage platform and the content provided on the Capital.com website is intended for informational purposes only and should not be regarded as an offer to sell or a solicitation of an offer to buy the products or securities to which it applies. No representation or warranty is given as to the accuracy or completeness of the information provided.
The information provided does not constitute investment advice nor take into account the individual financial circumstances or objectives of any investor. Any information that may be provided relating to past performance is not a reliable indicator of future results or performance.
To the extent permitted by law, in no event shall Capital.com (or any affiliate or employee) have any liability for any loss arising from the use of the information provided. Any person acting on the information does so entirely at their own risk.